Summary: Extracellular histamine in the striatum of con scious freely moving rats collected by intracerebral mi crodialysis 1 day after implantation of a V-shaped dialysis probe was measured by HPLC coupled with postcolumn o-phthalaldehyde derivatization fluorometry. The basal fractional histamine outputs were almost constant from 1 to 7 h after the start of perfusion (5.9-8.4 pg/30 min). Depolarization by perfusion with a high K + (100 mM) containing medium produced a significant (124%) in crease and neuronal blockade by perfusion with a tetro dotoxin (1 jLM)-containing medium resulted in a 68% re duction in the histamine output. The histamine output was markedly reduced by intraperitoneal injection of o:-fluoromethylhistidine (100 mg/kg) , an irreversible in hibitor of histidine decarboxylase, or (R)-o:-methyl histamine (5 mg/kg), a potent and specific H3-receptor Histamine (HA) exists in at least two classes of cellular stores in the mammalian brain, i. e., neurons and mast cells (Schwartz et a!. , 1986). Histaminer gic fibers are widely distributed in the brain, origi nating from cell bodies in the posterior hypothala mus (Watanabe et a!. , 1984), and histaminergic in nervation of the cerebral microvasculature has also been demonstrated (Steinbusch and Verhofstad, 1986;Takagi et a!. , 1986).There is some evidence that brain HA may play an important role in the regulation of blood-brain barrier (BBB) permeability: carotid artery infusion of HA increases BBB permeability (Dux and J06, Received March 20, 1991; final revision received October I, 1991; accepted October 7, 1991. Address correspondence and reprint requests to Dr. K. Saeki at Department of Pharmacology, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700, Japan.Abbreviations used: BBB, blood-brain barrier; a-FMH, a-flu oromethylhistidine; HA, histamine; MeA, middle cerebral ar tery. (R)-a-MH, (R)-a-methylhistamine.
477agonist. After middle cerebral artery (MCA) occlusion, the histamine output gradually increased, and reached four times the control value 8 h later. When rats were pretreated with metoprine (10 mg/kg), a histamine N methyltransferase inhibitor, there was no significant dif ference in the histamine output between the MCA occluded and the sham-operated groups during the first 3.5 h after the operation, but the histamine output grad ually increased thereafter in the MCA-occluded group. In rats treated with o:-fluoromethylhistidine, MCA occlusion failed to cause an increase in the histamine output. These results demonstrate that MCA occlusion induces a long lasting increase in neuronal histamine release in the rat striatum.